We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NVRO market cap is 410.93M. The company's latest EPS is USD -2.5335 and P/E is -4.45.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 205.47M | 113.84M | 96.33M | 108.81M | 103.86M |
Operating Income | 82.08M | -19.36M | -36.32M | -25.64M | -25.56M |
Net Income | 81.51M | -19.19M | -35.03M | -24.72M | -23.48M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 390.26M | 362.05M | 386.91M | 511.37M | 425.17M |
Operating Income | -96.48M | -62.85M | -110.93M | 6.16M | -99.31M |
Net Income | -103.69M | -83.07M | -131.36M | 3M | -92.21M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 605.51M | 602.41M | 574.42M | 569.52M | 561.58M |
Total Liabilities | 280.58M | 278.53M | 273.2M | 274.77M | 275.92M |
Total Equity | 324.94M | 323.88M | 301.23M | 294.75M | 285.67M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 469.65M | 789.43M | 574.54M | 602.41M | 635.71M |
Total Liabilities | 253.29M | 400.97M | 270.93M | 278.53M | 342.57M |
Total Equity | 216.35M | 388.46M | 303.62M | 323.88M | 293.15M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 38.1M | 24.68M | -29.31M | -43.82M | -49.91M |
Investing | 63.83M | 64.29M | -24.65M | -13.37M | -6.09M |
Financing | -3.83M | -2.46M | -2.27M | 1.85M | 836k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -50.23M | 1.19M | -41.88M | 24.68M | -58.83M |
Investing | 32.33M | -369.87M | 201.72M | 64.29M | -7.2M |
Financing | 32.09M | 346.91M | -169.38M | -2.46M | 49.53M |
Market Cap | 410.93M |
Price to Earnings Ratio | -4.45 |
Price to Sales Ratio | 0.97 |
Price to Cash Ratio | 3.94 |
Price to Book Ratio | 1.4 |
Dividend Yield | - |
Shares Outstanding | 36.4M |
Average Volume (1 week) | 945.72k |
Average Volume (1 Month) | 544.82k |
52 Week Change | -58.09% |
52 Week High | 28.89 |
52 Week Low | 10.265 |
Spread (Intraday) | 1.26 (10.61%) |
Company Name | Nevro Corp |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.nevro.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions